Efficacy of EGFR inhibition is modulated by model, sex, genetic background and diet: implications for preclinical cancer prevention and therapy trials. [electronic resource]
Producer: 20130321Description: e39552 p. digitalISSN:- 1932-6203
- Animals
- Antineoplastic Agents -- pharmacology
- Azoxymethane -- toxicity
- Colorectal Neoplasms -- chemically induced
- Diet
- Disease Models, Animal
- ErbB Receptors -- antagonists & inhibitors
- Female
- Male
- Mice
- Mice, Inbred C57BL
- Phosphorylation
- Quinazolines -- pharmacology
- Sex Factors
- Tyrphostins -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.